Increased SOAT2 expression in aged regulatory T cells is associated with altered cholesterol metabolism and reduced

Mingjiong Zhang1, Jiahua Cui2, Haoyan Chen1

  • 1Jiangsu Provincial Key Laboratory of Geriatrics, Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Nature Communications
|January 13, 2025
PubMed

Insights

Sterol O-acyltransferase 2 (SOAT2) is overexpressed in aging regulatory T (Treg) cells, impairing anti-tumor immunity in lung cancer. Targeting SOAT2 may improve immunotherapy for elderly cancer patients.

Area of Science:

  • Immunology
  • Oncology
  • Aging Research

Background:

  • Immune functions decline with aging, increasing cancer susceptibility.
  • Identifying aging-related molecular targets in elderly cancer patients is crucial.
  • Regulatory T (Treg) cells play a key role in immune regulation and cancer progression.

Purpose of the Study:

  • To investigate the role of sterol O-acyltransferase 2 (SOAT2) in aging-related immune dysfunction in lung squamous cell carcinoma (LSCC).
  • To explore SOAT2 as a potential therapeutic target for enhancing anti-tumor immunity in elderly cancer patients.

Main Methods:

  • Analysis of SOAT2 expression in Treg cells from elderly LSCC patients.
  • Radiomics analysis of LSCC patient data.
  • Ex vivo human and mouse Treg cell experiments.
  • In vivo mouse tumor models.
  • Investigation of the SREBP2-HMGCR-GGPP pathway.

Main Results:

  • SOAT2 is overexpressed in Treg cells of elderly LSCC patients.
  • Increased SOAT2 expression correlates with reduced immune infiltration and poor prognosis in LSCC.
  • SOAT2 overexpression in Treg cells enhances cholesterol metabolism via the SREBP2-HMGCR-GGPP pathway.
  • SOAT2 promotes Treg suppressive functions while inhibiting CD8+ T cell proliferation, migration, and anti-tumor immunity.

Conclusions:

  • SOAT2 overexpression in Treg cells contributes to immune aging and impaired anti-tumor immunity.
  • SOAT2 represents a potential therapeutic target for improving immunotherapy outcomes in elderly cancer patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K